PharmaShots Interview: Janssen’s Mark Wildgust Shares Insights on Imbruvica for Chronic Lymphocytic Leukemia and Darzalex for Mult...
May 2, 2022
PharmaShots Interview: Janssen's Mark Wildgust along with Two Other Key Speakers Share Insights on Data Presented at ASCO 2021
July 19, 2021
Janssen's Imbruvica (ibrutinib) + Rituximab Receives the EC's Marketing Authorization for Previously Untreated Patients with Chron...
September 8, 2020
Top 20 Prescription Drugs Based on 2019 Revenue
July 17, 2020
Back to Home
Incisive News in 3 Shots.
First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
Terms of Service
Copyright © 2023 PharmaShots - All Rights Reserved.